JPH0470027B2 - - Google Patents
Info
- Publication number
- JPH0470027B2 JPH0470027B2 JP59113495A JP11349584A JPH0470027B2 JP H0470027 B2 JPH0470027 B2 JP H0470027B2 JP 59113495 A JP59113495 A JP 59113495A JP 11349584 A JP11349584 A JP 11349584A JP H0470027 B2 JPH0470027 B2 JP H0470027B2
- Authority
- JP
- Japan
- Prior art keywords
- plasma
- purified
- molecular weight
- membrane module
- weight substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012528 membrane Substances 0.000 claims description 53
- 239000000126 substance Substances 0.000 claims description 35
- 210000004369 blood Anatomy 0.000 claims description 24
- 239000008280 blood Substances 0.000 claims description 24
- 210000000601 blood cell Anatomy 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 238000002637 fluid replacement therapy Methods 0.000 claims description 6
- 210000004180 plasmocyte Anatomy 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 120
- 239000000306 component Substances 0.000 description 23
- 238000000034 method Methods 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 108010088751 Albumins Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 3
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 206010051151 Hyperviscosity syndrome Diseases 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000001940 Massive Hepatic Necrosis Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010040968 SLE arthritis Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000000564 macroglobulinemia Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59113495A JPS60256465A (ja) | 1984-06-01 | 1984-06-01 | 血液の処理装置 |
EP85301121A EP0156496B1 (en) | 1984-02-24 | 1985-02-20 | Apparatus for the treatment of plasma |
DE8585301121T DE3570188D1 (en) | 1984-02-24 | 1985-02-20 | Apparatus for the treatment of plasma |
ES540645A ES8605992A1 (es) | 1984-02-24 | 1985-02-22 | Aparato para el tratamiento del plasma. |
US06/902,127 US4747952A (en) | 1984-02-24 | 1986-09-02 | Method and apparatus for plasma treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59113495A JPS60256465A (ja) | 1984-06-01 | 1984-06-01 | 血液の処理装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60256465A JPS60256465A (ja) | 1985-12-18 |
JPH0470027B2 true JPH0470027B2 (ko) | 1992-11-09 |
Family
ID=14613758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59113495A Granted JPS60256465A (ja) | 1984-02-24 | 1984-06-01 | 血液の処理装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60256465A (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6219177A (ja) * | 1985-07-17 | 1987-01-27 | 株式会社クラレ | 血液の処理装置 |
JPS6226072A (ja) * | 1985-07-26 | 1987-02-04 | 株式会社クラレ | 血液処理装置 |
EP1283064B1 (en) | 2001-08-10 | 2007-05-23 | Kuraray Co., Ltd. | Blood processing system |
-
1984
- 1984-06-01 JP JP59113495A patent/JPS60256465A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60256465A (ja) | 1985-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3885770B2 (ja) | 通気システム | |
EP0643593B1 (en) | Apparatus and methods for generating leukocyte free platelet concentrate --------------------------------------------------------- | |
US4747952A (en) | Method and apparatus for plasma treatment | |
US5863436A (en) | Venting system | |
KR20010090845A (ko) | 복막 투석에 있어서 단백질 손실을 방지하기 위한 방법 및장치 | |
JPH0470027B2 (ko) | ||
JPH0534989B2 (ko) | ||
JP2582852Y2 (ja) | 血液成分分離回路 | |
JPS60179065A (ja) | 血液処理装置 | |
JPS61193669A (ja) | 血漿の処理装置 | |
JPH10179731A (ja) | 血液処理装置および血液処理方法 | |
JPS61193668A (ja) | 血漿処理用装置 | |
JPS6219177A (ja) | 血液の処理装置 | |
JPS6327023B2 (ko) | ||
JPS60256466A (ja) | 血漿採取装置 | |
JPS6355353B2 (ko) | ||
JPS61191366A (ja) | 血漿処理装置 | |
JP2005000394A (ja) | 血液成分分離装置および血液成分の分離・移送方法 | |
JPH0653166B2 (ja) | 濃厚血液から血漿を回収する装置 | |
JPS6219176A (ja) | 血液処理用装置 | |
JPH0561949B2 (ko) | ||
JPH0228982B2 (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |